Renal failure related to angiotensin-converting enzyme inhibitors

Seminars in Nephrology

Volumn 17, Issue 1, 1997, Pages 67-76

  Textor, Stephen C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN II [1 SARCOSINE 8 THREONINE]; CAPTOPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

CLINICAL FEATURE; DRUG INDUCED DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; INCIDENCE; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY PLASMA FLOW; NEPHROTOXICITY; PATHOPHYSIOLOGY; POTASSIUM EXCRETION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM EXCRETION;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE; POTASSIUM; RISK FACTORS;

EID: 0031013539     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Brunner HR: ACE inhibitors in renal disease. Kidney Int 42:463-479, 1992
2. Hricik DE, Browning PJ, Kopelman R, et al: Captoprilinduced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney. N Engt J Med 308:377-381, 1983
3. Textor SC, Novick AC, Steinmuller DR, et al: Renal failure limiting antihypertensive therapy as an indication for renal revascularization. Arch Int Med 143:2208-2211, 1983
4. Devoy MA, Tomson CR, Edmunds ME, et al: Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J Int Med 232:493-498, 1992
5. Hollenberg NK: Treatment of hypertension: The place of angiotensin-converting enzyme inhibitors in the nineties. J Cardiovasc Pharmacol 20:S29-S332, 1992 (suppl)
6. Textor SC, Novick A, Mujais SK, et al: Responses of the stenosed and contralateral kidneys to (Sar-1, Thr-8) AII in human renovascular hypertension. Hypertension 5:796-804, 1983
7. Gansevoort RT, de Zeeuw D, de Jong PE: Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 45:861-867, 1994
8. Hollenberg NK, Swartz SL, Passan DR, et al: Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension. N Engl J Med 301:9-12, 1979
9. Textor SC, Tarazi RC, Novick AC, et al: Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril. Am J Med 76:29-37, 1984
10. Hollenberg NK, Williams GN, Burger G, et al: Blockade and stimulation of renal, adrenal and vascular receptors with 1-sar-8-ala-angiotension II in normal man. J Clin Inves 57:39-46, 1976
11. Edwards RM: Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 244:F526-F534, 1983
12. Sennesael J, Lamote J, Violet I, et al: Comparison of perindopril and amlodipine in cyclospsorine-treated renal allograft recipients. Hypertension 26:436-444, 1995
13. Mimran A: Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension. J Cardiovasc Pharmacol 19:S45-S50, 1992 (suppl 6)
14. Jackson B, Franze L, Sumithran E, et al: Pharmacologie nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat. J Lab Clin Med 115:21-27, 1990
15. Tillman DM, Malatino LS, Gumming AMM, et al: Enalapril in hypertension with renal artery stenosis: longterm follow-up and effects on renal function. J Hypertens 2:93-100, 1984 (suppl 2)
16. Jackson B, Matthews PG, McGrath BP, et al: Angiotensin converting enzyme inhibition in renovascular hypertension: Frequency of reversible renal failure. Lancet i:225-226, 1984
17. Franklin SS, Smith RD: Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Am J Med 79:14-23, 1985 (suppl 3c)
18. Speirs CJ, Dollery CT, Inman WHW, et al: Postmarketing surveillance of enalapril II: Investigation of the potential role of enalapril in deaths with renal failure. Br Med J 297:830-832, 1988
19. Hall JE, Guyton AC, Jackson TE, et al: Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 233:F366-F372, 1977
20. Zatz R, Dunn RB, Meyer TW, et al: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
21. Toto RD, Mitchell HC, Lee HC, et al: Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis. Ann Int Med 115:513-519, 1991
22. Abuelo JG: Diagnosing vascular causes of renal failure. Ann Int Med 123:601-614, 1995
23. Hricik DE: Captopril-induced renal insufficiency and the role of sodium balance. Ann Intern Med 103:222-223, 1985
24. Textor SC: ACE inhibitors in renovascular hypertension. Cardiovasc Drugs Ther 4:229-235, 1990
25. Patrono C, Dünn MJ: The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 32:1-12, 1987
26. Grone HJ, Helmchen U: Impairment and recovery of the clipped kidney in two kidney, one clip hypertensive rats during and after antihypertensive therapy. Lab Invest 54:645-655, 1986
27. Textor SC: Pathophysiology of renal failure in ischemie nephropathy. Am J Kidney Dis 24:642-651, 1994
28. Shanley PF: The pathology of chronic renal ischemia. Semin Nephrol 16:21-32, 1996
29. Textor SC, Bravo EL, Fouad FM, et al: Hyperkalemia in azotemic patients during angiotensin converting enzyme inhibition and aldosterone reduction with captopril. Am J Med 73:719-725, 1982
30. Doman K, Perlmutter JA, Muhammedi M, et al: Lifethreatening hyperkalemia associated with captopril administration. South Med J 86:1269-1272, 1993
31. Tadena L, Textor SC, Bravo EL: Potassium homeostasis during long-term converting enzyme inhibition with captopril in hypertensive patients. Clin Res 29:778A, 1981 (abstr)
32. MacGregor GA: Blood pressure, angiotensin-converting enzyme (ACE) inhibitors, and the kidney. Am J Med 92:20s-26s, 1992 (suppl 4B)
33. Oster JR, Materson BJ: Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors. Arch Int Med 152:704-710, 1992
34. Munger MA: Renal functional alterations induced by angiotensin-converting enzyme inhibitors in heart failure. Ann Pharmacother 27:205-210, 1993
35. Nakhoul F, Belter OS: Acute renal failure following massive mannitol infusion and enalapril treatment. Clin Nephrol 44:118-120, 1995
36. Textor SC, Biscardi A, Bravo EL, et al: Acute renal failure during converting enzyme inhibition in patients with renal artery stenosis. Am Soc Nephrol 10:45A, 1982 (abstr)
37. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293-302, 1991
38. Lewis EJ, Hunsicker LG, Bain RP, et al: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
39. Remuzzi A, Perticucci E, Ruggenenti P, et al: Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 39:1267-1273, 1991
40. Maschio G, Albert! D, Janin G, et al: Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
41. Levy B.SafarME: Remodelling of the vascular system in response to hypertension and drug therapy. Clin Exp Pharmacol Physiol 19:33-37, 1992 (suppl 19)
42. Paul LC, Benediktsson H: Post-transplant hypertension and chronic renal allograft failure. Kidney Int 48:S-34-S-37, 1995 (suppl 92)
43. Burdmann EA, Andoh TF, Nast CC, et al: Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 269:F491-F499, 1995
44. Auch-Schwelk W, Duske E, Hink U, et al: Vasomotor responses in cyclosporine A treated rats after chronic angiotensin blockade. Hypertension 23:832-837, 1994
45. Anderson S, Rennke HG, Zatz R: Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats. Am J Physiol 267:F35-F43, 1994
46. Vargas AV, Robinson AV, Schulak JA: Captopril amelioration of renal reperfusion injury. J Surg Res 57:28-32, 1994
47. Hulton SA, Thomson PD, Cooper PA, et al: Angiotensin-converting enzyme inhibitors in pregnancy may result in neonatal renal failure. S Afr Med J 78:673-676, 1990
48. Swedberg K, Held P, Kjekshus J, et al: Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the cooperative new Scandinavian enalapril survival study II (CONSENSUS II). N Engl J Med 327:678-684, 1992
49. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685-691, 1992